Timmis A, Vardas P, Townsend N, Torbica A, Katus H, De Smedt D et al (2022) European Society of Cardiology: cardiovascular disease statistics 2021. Eur Heart J 43(8):716–799

Article  PubMed  Google Scholar 

Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, He XY et al (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci USA 94(21):11514–11519

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ago T, Sadoshima J (2006) GDF15, a cardioprotective TGF-beta superfamily protein. Circul Res 98(3):294–297

Article  CAS  Google Scholar 

Kempf T, Eden M, Strelau J, Naguib M, Willenbockel C, Tongers J et al (2006) The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circul Res 98(3):351–360

Article  CAS  Google Scholar 

Wollert KC, Kempf T, Wallentin L (2017) Growth differentiation factor 15 as a Biomarker in Cardiovascular Disease. Clin Chem 63(1):140–151

Article  CAS  PubMed  Google Scholar 

Lind L, Wallentin L, Kempf T, Tapken H, Quint A, Lindahl B et al (2009) Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the prospective investigation of the vasculature in Uppsala seniors (PIVUS) study. Eur Heart J 30(19):2346–2353

Article  CAS  PubMed  Google Scholar 

Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E (2011) Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study. Circulation 123(19):2101–2110

Article  PubMed  PubMed Central  Google Scholar 

Rohatgi A, Patel P, Das SR, Ayers CR, Khera A, Martinez-Rumayor A et al (2012) Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study. Clin Chem 58(1):172–182

Article  CAS  PubMed  Google Scholar 

Wallentin L, Zethelius B, Berglund L, Eggers KM, Lind L, Lindahl B et al (2013) GDF-15 for prognostication of cardiovascular and cancer morbidity and mortality in men. PLoS ONE 8(12):e78797

Article  PubMed  PubMed Central  Google Scholar 

Wiklund FE, Bennet AM, Magnusson PK, Eriksson UK, Lindmark F, Wu L et al (2010) Macrophage inhibitory cytokine-1 (MIC-1/GDF15): a new marker of all-cause mortality. Aging Cell 9(6):1057–1064

Article  CAS  PubMed  Google Scholar 

Ho JE, Hwang SJ, Wollert KC, Larson MG, Cheng S, Kempf T et al (2013) Biomarkers of cardiovascular stress and incident chronic kidney disease. Clin Chem 59(11):1613–1620

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang TJ, Wollert KC, Larson MG, Coglianese E, McCabe EL, Cheng S et al (2012) Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 126(13):1596–1604

Article  CAS  PubMed  Google Scholar 

Kempf T, Björklund E, Olofsson S, Lindahl B, Allhoff T, Peter T et al (2007) Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J 28(23):2858–2865

Article  CAS  PubMed  Google Scholar 

Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB et al (2009) Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J 30(9):1057–1065

Article  CAS  PubMed  Google Scholar 

Bonaca MP, Morrow DA, Braunwald E, Cannon CP, Jiang S, Breher S et al (2011) Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22. Arteriosclerosis, thrombosis, and vascular biology. 31(1):203–210

Dominguez-Rodriguez A, Abreu-Gonzalez P, Hernandez-Baldomero IF, Avanzas P, Bosa-Ojeda F (2014) Change in growth differentiation factor 15, but not C-reactive protein, independently predicts major cardiac events in patients with non-ST elevation acute coronary syndrome. Mediat Inflamm 2014:929536

Article  Google Scholar 

Fuernau G, Poenisch C, Eitel I, de Waha S, Desch S, Schuler G et al (2014) Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial. Eur J Heart Fail 16(8):880–887

Article  CAS  PubMed  Google Scholar 

Hagström E, James SK, Bertilsson M, Becker RC, Himmelmann A, Husted S et al (2016) Growth differentiation factor-15 level predicts major bleeding and cardiovascular events in patients with acute coronary syndromes: results from the PLATO study. Eur Heart J 37(16):1325–1333

Article  PubMed  Google Scholar 

Dominguez-Rodriguez A, Abreu-Gonzalez P, Avanzas P, Consuegra-Sanchez L (2016) Effect of serum growth differentiation Factor-15 and the Syntax score on 2-Year outcomes in patients with Acute Coronary Syndrome. Am J Cardiol 117(10):1569–1574

Article  CAS  PubMed  Google Scholar 

Wollert KC, Kempf T, Peter T, Olofsson S, James S, Johnston N et al (2007) Prognostic value of growth-differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 115(8):962–971

Article  CAS  PubMed  Google Scholar 

Kempf T, Sinning JM, Quint A, Bickel C, Sinning C, Wild PS et al (2009) Growth-differentiation factor-15 for risk stratification in patients with stable and unstable coronary heart disease: results from the AtheroGene study. Circulation Cardiovasc Genet 2(3):286–292

Article  CAS  Google Scholar 

Schopfer DW, Ku IA, Regan M, Whooley MA (2014) Growth differentiation factor 15 and cardiovascular events in patients with stable ischemic heart disease (the Heart and Soul Study). Am Heart J 167(2):186–92e1

Article  CAS  PubMed  Google Scholar 

Dallmeier D, Brenner H, Mons U, Rottbauer W, Koenig W, Rothenbacher D (2016) Growth differentiation factor 15, its 12-Month relative change, and risk of Cardiovascular events and total mortality in patients with stable Coronary Heart Disease: 10-Year follow-up of the KAROLA Study. Clin Chem 62(7):982–992

Article  CAS  PubMed  Google Scholar 

Hagström E, Held C, Stewart RA, Aylward PE, Budaj A, Cannon CP et al (2017) Growth differentiation factor 15 predicts all-cause morbidity and mortality in stable Coronary Heart Disease. Clin Chem 63(1):325–333

Article  PubMed  Google Scholar 

D’Agostino RB, Sr., Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM et al (2008) General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117(6):743–753

Article  PubMed  Google Scholar 

Pearson GJ, Thanassoulis G, Anderson TJ, Barry AR, Couture P, Dayan N et al (2021) 2021 Canadian Cardiovascular Society Guidelines for the management of Dyslipidemia for the Prevention of Cardiovascular Disease in adults. Can J Cardiol 37(8):1129–1150

Article  PubMed  Google Scholar 

Cai YL, Hao BC, Chen JQ, Li YR, Liu HB (2022) Correlation between plasma proteomics and adverse outcomes among older men with chronic coronary syndrome. Front Cardiovasc Med 9:867646

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lawton JS, Tamis-Holland JE, Bangalore S, Bates ER, Beckie TM, Bischoff JM et al (2022) 2021 ACC/AHA/SCAI Guideline for Coronary Artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol 79(2):e21–e129

Article  PubMed  Google Scholar 

Metra M, Ponikowski P, Dickstein K, McMurray JJ, Gavazzi A, Bergh CH et al (2007) Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 9(6–7):684–694

Article  PubMed  Google Scholar 

Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17(10):2937–2944

Article  PubMed  Google Scholar 

Eggers KM, Kempf T, Lagerqvist B, Lindahl B, Olofsson S, Jantzen F et al (2010) Growth-differentiation factor-15 for long-term risk prediction in patients stabilized after an episode of non-ST-segment-elevation acute coronary syndrome. Circulation Cardiovasc Genet 3(1):88–96

Article  CAS  Google Scholar